Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance
Bin Li(First Affiliated Hospital of Henan University), Annie LM Cheung(City University of Hong Kong, Shenzhen Research Institute)
Cited by 58
Related Papers
Targeting PI3K/Akt signal transduction for cancer therapy
|Signal Transduction and Targeted Therapy|2021|1.7k
Advances in targeted therapy for esophageal cancer
|Signal Transduction and Targeted Therapy|2020|546
Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment
|MedComm|2021|369